Revive TherapeuticsRVVTF
13F holders, Q3 2025 (September 30)2holders +1
1new positions
0sold out
$0.01avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding Revive Therapeutics Ltd. (RVVTF) in their 13F filings, up 1 from Q2 2025. 1 opened new positions and 0 sold out. The largest holders were FineMark National Bank & Trust ($114) and Curio Wealth, LLC ($11).
- Company
- Revive Therapeutics Ltd.
- CUSIP
- 761516103
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $11 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 1,000 shares bought, net +1,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| FineMark National Bank & Trust | 0.00% | No change | 10,345 | $114 |
| Curio Wealth, LLC | 0.00% | New | 1,000 | $11 |
"% of holder's portfolio" is RVVTF's weight in each manager's 13F, not the share of Revive Therapeutics Ltd. the manager owns.